Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivian T Thieu

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The EMBO Journal|March 24, 2007
Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18Ralpha gene during Th1 differentiationQing Yu, Vivian T Thieu, Mark H Kaplan
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 7, 2022
The Association Between HbA1c and 1-Year Diabetes-Related Medical Costs: A Retrospective Claims Database AnalysisKristina S Boye, Maureen J Lage, Vivian T Thieu
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2023
An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort StudyKristina S Boye, Jay P Bae, Vivian T Thieu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2025
Therapeutic Inertia in an Insured Population with Type 2 Diabetes in the United States: A Retrospective Cohort StudyKristina S Boye, Maureen J Lage, Kendra A Terrell, et al.
Diabetes, Obesity & Metabolism|December 11, 2019
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagonVivian T Thieu, Beth D Mitchell, Oralee J Varnado, et al.
Patient Preference and Adherence|January 13, 2022
Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative ReviewKristina S Boye, Shraddha Shinde, Tessa Kennedy-Martin, et al.
Advances in Therapy|March 22, 2022
The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective StudyKristina S Boye, Vivian T Thieu, Maureen J Lage, et al.
Journal of the Endocrine Society|May 8, 2023
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)Clare J Lee, Huzhang Mao, Vivian T Thieu, et al.
Diabetes, Obesity & Metabolism|August 1, 2025
HbA1c reduction with tirzepatide in people with type 2 diabetes: The contribution of weight loss assessed by a mediation analysisTina Vilsbøll, Maciej T Malecki, Palash Sharma, et al.
Patient Preference and Adherence|May 23, 2019
Patient preferences for glucagon-like peptide 1 receptor-agonist treatment attributesVivian T Thieu, Susan Robinson, Tessa Kennedy-Martin, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The EMBO Journal|March 24, 2007
Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18Ralpha gene during Th1 differentiationQing Yu, Vivian T Thieu, Mark H Kaplan
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 7, 2022
The Association Between HbA1c and 1-Year Diabetes-Related Medical Costs: A Retrospective Claims Database AnalysisKristina S Boye, Maureen J Lage, Vivian T Thieu
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2023
An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort StudyKristina S Boye, Jay P Bae, Vivian T Thieu, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 9, 2025
Therapeutic Inertia in an Insured Population with Type 2 Diabetes in the United States: A Retrospective Cohort StudyKristina S Boye, Maureen J Lage, Kendra A Terrell, et al.
Diabetes, Obesity & Metabolism|December 11, 2019
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagonVivian T Thieu, Beth D Mitchell, Oralee J Varnado, et al.
Patient Preference and Adherence|January 13, 2022
Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative ReviewKristina S Boye, Shraddha Shinde, Tessa Kennedy-Martin, et al.
Advances in Therapy|March 22, 2022
The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective StudyKristina S Boye, Vivian T Thieu, Maureen J Lage, et al.
Journal of the Endocrine Society|May 8, 2023
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)Clare J Lee, Huzhang Mao, Vivian T Thieu, et al.
Diabetes, Obesity & Metabolism|August 1, 2025
HbA1c reduction with tirzepatide in people with type 2 diabetes: The contribution of weight loss assessed by a mediation analysisTina Vilsbøll, Maciej T Malecki, Palash Sharma, et al.
Patient Preference and Adherence|May 23, 2019
Patient preferences for glucagon-like peptide 1 receptor-agonist treatment attributesVivian T Thieu, Susan Robinson, Tessa Kennedy-Martin, et al.
Pageof 3